Xrmi Groups advocating for VP nominee Kamala Harris to receive fair, non-sexist coverage
Federal health officials are sounding the alarm about a dire and alarming increase in the number of babies born with syphilis, which can cause lifelong health problems and even death for newborns.New datafrom the Centers for Disease Control and Prevention Tuesday shows the number of newborn syphilis cases has risen more than tenfold from 2012 to 2022 and is at its highest level in at least 30 years, w
stanley quencher ith 3,761 infants born with the infection last year.Of these cases, 231 were stillbirths, and 51 were infant deaths.Syphilisis a sexually transmitted infection that can linger in the body for years, becoming more dangerous if left untreated.An infected, untreated pregnant woman can pass it to her fetus, known as congenitalsyphilis. This can cause miscarriage, stillbirth or newborn death. The babies that survive can develop seri
stanley canada ous issues, such as blindness, deafness, developmental delays or skeletal abnormalities, according to the CDC.The congenital disease is almost entirely preventable through appropriate screening and treatment, with just a single penicillin injection at least 30 days before delivery nearly always preventing the disease from spreading to an unborn baby. An
stanley cup quencher d even though the U.S. is facing a shortage of the drug, the CDC has encouraged health care providers to prioritize congenital cases in giving the treatment.SEE MORE: Groups urge White House to act on syphilis drug shortageDespite the ability to treat congenital syphilis, almost 9 out of 10 of the babies Hrca US stocks slip deeper into a slump as Dow enters bear market
Pfizer/BioNTech has officially filed with the Food and Drug Administration seeking to expand their emergency use authorization for their COVID-19 vaccine in children aged 12 to 15 years old.When the Pfizer COVID-19 vaccine was approved for emergency use by the FDA in December, it was for those aged 16 and older.
stanley mugs Since then, the company has conducted studies on the vaccine s efficacy in younger teens. Pending regulatory decision, our hope is to make this vaccine available to the 12-15-year-old age group before the start of the 2021 school year, the company tweeted Friday.In March, they published data showing their COVID-19 two-shot vaccine was safe and produced a robust antibody response in trial participants aged 12 to 15. The findings recorded 100% efficacy against the virus in the study of 2,260 adolescents between 12 and 15 years of age. Of the 1,000 participants given the vaccine, none developed a COVID-19 infection. In the more than 1,000 participants given the placebo, 18 contracted COVID-19. BREAKING: Today, with @BioNTech_Group, we submitted a request to US FDA to expand emergency use of our COVID-19 vaccine to adolescents 12 to 15 years of age. pic.twitter/AHjc2khnUjmdash; Pfizer In
stanley cup c. @pfizer April 9, 2021 .Page-below > .RichTextModule di
stanley website splay:none; .Page-below .Link font-size: 12px; padding: 5px 10px;border: 1px solid 005687;border-radius: 4px;font-family: proxima-nova , sans-serif; Report a typo
